Julian Großkreutz

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser et al. · The Lancet Neurology · 2018 · 492 citations · Full text

Prognostic Assessment, Neurodegenerative Diseases, Personalised Prediction Model +12

The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons

Helmuth Adelsberger, Stefan Quasthoff, Julian Großkreutz et al. · European Journal of Pharmacology · 2000 · 282 citations

Molecular Physiology, Hyperpolarization (Biology), Neurophysiology +12

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

Emily Feneberg, Patrick Oeckl, Petra Steinacker et al. · Neurology · 2017 · 213 citations

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis

Simon Witzel, André Maier, Robert Steinbach et al. · JAMA Neurology · 2022 · 176 citations · Full text